Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ADEFOVIR DIPIVOXIL Cause Hepatitis b reactivation? 54 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 54 reports of Hepatitis b reactivation have been filed in association with ADEFOVIR DIPIVOXIL (Adefovir dipivoxil). This represents 2.6% of all adverse event reports for ADEFOVIR DIPIVOXIL.

54
Reports of Hepatitis b reactivation with ADEFOVIR DIPIVOXIL
2.6%
of all ADEFOVIR DIPIVOXIL reports
1
Deaths
10
Hospitalizations

How Dangerous Is Hepatitis b reactivation From ADEFOVIR DIPIVOXIL?

Of the 54 reports, 1 (1.9%) resulted in death, 10 (18.5%) required hospitalization.

Is Hepatitis b reactivation Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ADEFOVIR DIPIVOXIL. However, 54 reports have been filed with the FAERS database.

What Other Side Effects Does ADEFOVIR DIPIVOXIL Cause?

Drug resistance (417) Osteomalacia (409) Hypophosphataemia (368) Fanconi syndrome acquired (304) Osteoporosis (224) Bone pain (213) Renal impairment (203) Drug ineffective (195) Arthralgia (174) Blood phosphorus decreased (150)

What Other Drugs Cause Hepatitis b reactivation?

RITUXIMAB (914) CYCLOPHOSPHAMIDE (801) DOXORUBICIN (684) VINCRISTINE (641) PREDNISONE (583) PREDNISOLONE (465) LAMIVUDINE (308) METHOTREXATE (305) DEXAMETHASONE (293) ETOPOSIDE (213)

Which ADEFOVIR DIPIVOXIL Alternatives Have Lower Hepatitis b reactivation Risk?

ADEFOVIR DIPIVOXIL vs ADEMETIONINE ADEFOVIR DIPIVOXIL vs ADENOSINE ADEFOVIR DIPIVOXIL vs ADO-TRASTUZUMAB EMTANSINE ADEFOVIR DIPIVOXIL vs ADRIAMYCIN ADEFOVIR DIPIVOXIL vs ADUCANUMAB

Related Pages

ADEFOVIR DIPIVOXIL Full Profile All Hepatitis b reactivation Reports All Drugs Causing Hepatitis b reactivation ADEFOVIR DIPIVOXIL Demographics